ACGT Fellow Obliterates Tumors in Leukemia Patients

Aug 12, 2011

ACGT research fellow, Dr. Carl June and his team at University of Pennsylvania Abramson Cancer Center are making great strides for the treatment of advanced CLL (chronic lymphocytic leukemia). The clinical trial, funded by ACGT, uses genetically-modified versions of the patient’s own T cells, and has shown remission for up to a year in a small group of patients, several of whom are in complete remission.

Read about the story from these sources:

NBC Nightly News with Brian Williams covers the story, August 11, 2011
Interview with Co-Founder Barbara Netter on FoxNews, August 11, 2011
Read the article in New England Journal of Medicine.
Read the article in Science Translational Medicine.
View the University of Pennsylvania video featuring Dr. Carl June.